Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +0.56%42 PB Ratio is 1.07 as of Aug. 04, 2026, which is 27% below its 10-year median of 1.46. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 111 Medical Distribution companies, Amwill Health Care ranks worse than 54.95% on this metric.
The historical rank and industry rank for Amwill Health Care's PB Ratio or its related term are showing as below:
BOM:544353'
s PB Ratio Range Over the Past 10 Years
Min: 0.77 Med: 1.46 Max: 11.47
Current: 1.06
During the past 6 years, Amwill Health Care's highest PB Ratio was 11.47. The lowest was 0.77. And the median was 1.46.
BOM:544353's PB Ratio is ranked worse than 54.95% of 111
companies
in the Medical Distribution industry
Industry Median: 0.99
vs BOM:544353: 1.06
During the past 12 months, Amwill Health Care's average Book Value Per Share Growth Rate was 16.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 159.70% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Amwill Health Care was 259.60% per year. The lowest was 159.70% per year. And the median was 209.65% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Amwill Health Care PB Ratio Related Terms
Amwill Health Care PB Ratio Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amwill Health Care's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's PB Ratio distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Amwill Health Care (BOM:544353) has a PB Ratio of 1.07 as of Aug. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Amwill Health Care and its competitors. This is 27% below median its historical median of 1.46. Over the past decade, Amwill Health Care's PB Ratio has ranged from 0.77 to 11.47. According to the industry distribution chart, Amwill Health Care ranks #61 out of 111 companies in the Medical Distribution industry, placing it in the top 55%.
Is Amwill Health Care's PB Ratio too high?
Amwill Health Care's current PB Ratio of 1.07 is 27% below median its 10-year median of 1.46. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 11.47. The Medical Distribution industry median PB Ratio is 0.99. Amwill Health Care's value of 1.07 is 8.1% above this industry median. Based on the distribution chart, Amwill Health Care ranks #61 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #61 out of 111 companies for PB Ratio. This places Amwill Health Care in the lower half of its industry. The industry median PB Ratio is 0.99. Amwill Health Care's value of 1.07 is 8.1% above this benchmark. Historically, Amwill Health Care's own PB Ratio has ranged from 0.77 to 11.47 over the past decade. While the company's 10-year median is 1.46 vs. the industry median of 0.99, Amwill Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 0.99, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current PB Ratio of 1.07 is 8.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median PB Ratio is 0.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current PB Ratio is 1.07, which is 27% below median its own 10-year median of 1.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current PB Ratio of 1.07. The current PB Ratio is 1.07, which is 27% below median its 10-year median of 1.46 and 8.1% above the Medical Distribution industry median of 0.99. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current PB Ratio is 1.07 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score
Get the complete analysis for BOM:544353
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
